Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totaling 3,370 shares, a drop of 22.2% from the March 31st total of 4,334 shares. Based on an average daily volume of 53,197 shares, the days-to-cover ratio is presently 0.1 days.

Alpha Tau Medical Trading Up 9.5%

Shares of NASDAQ DRTSW traded up $0.12 during mid-day trading on Friday, reaching $1.34. The company had a trading volume of 58,125 shares, compared to its average volume of 48,147. The business’s 50-day moving average is $1.00 and its 200-day moving average is $0.70. Alpha Tau Medical has a 52 week low of $0.18 and a 52 week high of $1.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.